Kindly Md, INC Form 4 insider transactions

Nakamoto Inc. CEO David F. Bailey acquired 55,115 shares of common stock in open market transactions.

CEO David Bailey acquired 136,333 shares of Nakamoto Inc. common stock through open market purchases between May 26 and May 27, 2026.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, was granted 600,000 shares of common stock as part of his 2025 bonus payment.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, filed an amended Form 4 to correct a scrivener's error regarding his beneficial ownership of common stock and derivative securities following recent mergers.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, significantly increased his beneficial ownership of common stock and stock options following two merger agreements.

Nakamoto Inc. CEO David F. Bailey significantly increased his beneficial ownership of common stock following two merger agreements.

Nakamoto Inc.'s Chief Commercial Officer, Andrew John Creighton, acquired 1,685,500 fully vested stock options at an exercise price of $0.43, assumed as part of a recent merger.

Kindly MD, Inc. Chief Accounting Officer John Merritt Dalton was granted 1,574,803 restricted stock units, vesting over four years.

Kindly MD, Inc.'s Chief Financial Officer, Teresa S. Gendron, was granted 2,624,671 restricted stock units, vesting over four years.

Kindly MD's Chief Financial Officer, Jared Barrera, reported the vesting of a restricted stock award of 6,400 common shares, increasing his beneficial ownership to 22,242 shares.

Timothy Pickett, Chief Medical Officer and Director of Kindly MD, Inc., acquired 191,271 shares of common stock through restricted stock units and awards.

Kindly MD, Inc. Director Eric Stanton Weiss was granted 112,781 restricted stock units, vesting on August 15, 2026.

Kindly MD, Inc. Director Gregory Elias Xethalis was granted 112,781 Restricted Stock Units (RSUs) as part of his compensation.

Kindly MD's Chief Operating Officer, Amanda Fabiano, was granted over 4.1 million Restricted Stock Units, subject to time-based vesting and a performance condition.

Kindly MD, Inc. CEO David F. Bailey was granted 751,879 restricted stock units, vesting over four years, as reported in a recent SEC Form 4 filing.

Kindly MD's Chief Commercial Officer, Andrew John Creighton, acquired 601,503 restricted stock units with a four-year vesting schedule.

Kindly MD's Chief Investment Officer, Tyler Matthew Evans, was granted 601,503 restricted stock units with a four-year vesting schedule.

Kindly MD Director Mark W. Yusko acquired 112,781 shares of common stock through restricted stock units, increasing his beneficial ownership to 2,212,781 shares.

Kindly MD, Inc. Director Perianne Boring McNulty was granted 112,781 restricted stock units, vesting in August 2026.

Kindly MD, Inc. Director Charles Phillip Blackburn was granted 112,781 restricted stock units, vesting in August 2026.

Kindly MD's Chief Investment Officer, Tyler Matthew Evans, acquired 2,232,114 shares of common stock, increasing his beneficial ownership.

Kindly MD's Chief Compliance Officer, Andrew Creighton, acquired over 2.2 million shares of common stock at no cost, increasing his beneficial ownership.

Kindly MD, Inc.'s CEO, David F. Bailey, reported the acquisition of over 11 million shares of common stock.

Director Christian S. Robinson reports acquisition of common stock and options in Kindly MD, Inc.

Director Gary Seelhorst reports acquisition and disposal of Kindly MD, Inc. stock and options.

Director Amy Powell reports transactions involving Kindly MD, Inc. shares and options, including acquisition of common stock for services and options vesting upon a change in control.

Kindly MD, Inc. CEO Timothy Pickett reports acquisition of common stock and options, signaling potential confidence in the company's future.

Jared Barrera, CFO of Kindly MD, Inc., reports the acquisition of 35,000 options with an exercise price of $3.90.

Adam Cox, COO of Kindly MD, Inc., reports the acquisition of 40,000 options exercisable for common stock.

Director Amy Powell reports the acquisition and disposal of Kindly MD, Inc. common stock on October 24, 2024.